Plk1-mediated Phosphorylation of Topors Regulates p53 Stability

被引:83
作者
Yang, Xiaoming [1 ,2 ]
Li, Hongchang [1 ]
Zhou, Zinan [1 ]
Wang, Wen-Horng [3 ]
Deng, Anping [2 ]
Andrisani, Ourania [3 ]
Liu, Xiaoqi [1 ]
机构
[1] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA
[2] Sichuan Univ, Coll Chem, Chengdu 610064, Peoples R China
[3] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA
基金
美国国家卫生研究院;
关键词
TOPOISOMERASE-I-BINDING; POLO-LIKE KINASES; PLK1; PHOSPHORYLATION; TUMOR-SUPPRESSOR; CANCER-CELLS; PROTEIN; IDENTIFICATION; UBIQUITIN; LIGASE; VITRO;
D O I
10.1074/jbc.C109.001560
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Polo-like kinase 1 (Plk1) overexpression is associated with tumorigenesis by an unknown mechanism. Likewise, Plk1 was suggested to act as a negative regulator of tumor suppressor p53, but the mechanism remains to be determined. Herein, we have identified topoisomerase I-binding protein (Topors), a p53-binding protein, as a Plk1 target. We show that Plk1 phosphorylates Topors on Ser(718) in vivo. Significantly, expression of a Plk1-unphosphorylatable Topors mutant (S718A) leads to a dramatic accumulation of p53 through inhibition of p53 degradation. Topors is an ubiquitin and small ubiquitin-like modifier ubiquitin-protein isopeptide ligase (SUMO E3) ligase. Plk1-mediated phosphorylation of Topors inhibits Topors-mediated sumoylation of p53, whereas p53 ubiquitination is enhanced, leading to p53 degradation. These results demonstrate that Plk1 modulates Topors activity in suppressing p53 function and identify a likely mechanism for the tumorigenic potential of Plk1.
引用
收藏
页码:18588 / 18592
页数:5
相关论文
共 28 条
[1]   Polo-like kinase 1 (Plk1) inhibits p53 function by physical interaction and phosphorylation [J].
Ando, K ;
Ozaki, T ;
Yamamoto, H ;
Furuya, K ;
Hosoda, M ;
Hayashi, S ;
Fukuzawa, M ;
Nakagawara, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (24) :25549-25561
[2]  
Andrisani OM, 1999, INT J ONCOL, V15, P373
[3]   Large-scale characterization of HeLa cell nuclear phosphoproteins [J].
Beausoleil, SA ;
Jedrychowski, M ;
Schwartz, D ;
Elias, JE ;
Villén, J ;
Li, JX ;
Cohn, MA ;
Cantley, LC ;
Gygi, SP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (33) :12130-12135
[4]   Gene expression patterns in human liver cancers [J].
Chen, X ;
Cheung, ST ;
So, S ;
Fan, ST ;
Barry, C ;
Higgins, J ;
Lai, KM ;
Ji, JF ;
Dudoit, S ;
Ng, IOL ;
van de Rijn, M ;
Botstein, D ;
Brown, PO .
MOLECULAR BIOLOGY OF THE CELL, 2002, 13 (06) :1929-1939
[5]   Polo-like kinases and oncogenesis [J].
Eckerdt, F ;
Yuan, JP ;
Strebhardt, K .
ONCOGENE, 2005, 24 (02) :267-276
[6]   Proteomic screen finds pSer/pThr-binding domain localizing Plk1 to mitotic substrates [J].
Elia, AEH ;
Cantley, LC ;
Yaffe, MB .
SCIENCE, 2003, 299 (5610) :1228-1231
[7]   Ubiquitination by TOPORS regulates the prostate tumor suppressor NKX3.1 [J].
Guan, Bin ;
Pungaliya, Pooja ;
Li, Xiang ;
Uquillas, Carlos ;
Mutton, Laura N. ;
Rubin, Eric H. ;
Bieberich, Charles J. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (08) :4834-4840
[8]   Interaction between human topoisomerase I and a novel RING finger/arginine-serine protein [J].
Haluska, P ;
Saleem, A ;
Rasheed, Z ;
Ahmed, F ;
Su, EW ;
Liu, LF ;
Rubin, EH .
NUCLEIC ACIDS RESEARCH, 1999, 27 (12) :2538-2544
[9]   The E3 ligase Topors induces the accumulation of polysumoylated forms of DNA topoisomerase I in vitro and in vivo [J].
Hammer, Eva ;
Heilbronn, Regine ;
Weger, Stefan .
FEBS LETTERS, 2007, 581 (28) :5418-5424
[10]   Normal cells, but not cancer cells, survive severe Plk1 depletion [J].
Liu, XQ ;
Lei, M ;
Erikson, RL .
MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (06) :2093-2108